13.73
Ventyx Biosciences Inc (VTYX) 最新ニュース
Lilly to acquire Ventyx Biosciences stock for $1.2 billion, Canaccord cuts rating - Investing.com Canada
UBS downgrades Ventyx Biosciences stock to Neutral on Eli Lilly acquisition - Investing.com Canada
Eli Lilly to acquire Ventyx Biosciences stock for $1.2 billion as Clear Street downgrades - Investing.com
Lilly Commits $1.2B to Transform Oral Therapy Landscape with Ventyx Acquisition - geneonline.com
Lilly Inks $1.2bn Deal For Ventyx In Broader Pipeline Expansion - Citeline News & Insights
Significant price jump for US biotech company - medwatch.com
Ventyx downgraded to Market Perform from Outperform at LifeSci Capital - TipRanks
Eli Lilly to Acquire Drug Developer Ventyx for $1.2 Billion, Expanding in Autoimmune Field - Bitget
Lilly to buy Ventyx Biosciences for $1.2 billion - Indian Pharma Post
Shareholder Alert: The Ademi Firm investigates whether Ventyx Biosciences, Inc. is obtaining a Fair Price for its Public Shareholders - Morningstar
Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion, Expanding Inflammation Portfolio - NAI500
Confirming rumours, Lilly to buy Ventyx in $1.2B deal - FirstWord
Eli Lilly confirms plan to buy Ventyx Biosciences in $1.2 billion deal - MSN
Eli Lilly confirms deal to buy Ventyx Biosciences for $14 a share - MSN
Eli Lilly to buy Ventyx Biosciences for $1.2 billion - 104.1 WIKY
Eli Lilly (LLY) Acquires Ventyx Biosciences for $1.2 Billion - GuruFocus
Ventyx stock jumps on Lilly’s $1.2 billion buyout — and why it’s still trading under $14 - TechStock²
Lilly snaps up Ventyx for $1.2B in pursuit of oral immune drugs - BioPharma Dive
Eli Lilly to buy Ventyx Biosciences for $1.2bn - MLex
Eli Lilly to Acquire Ventyx Biosciences in Cash Deal - TipRanks
Lilly moves beyond blockbuster obesity drugs with $1.2 billion Ventyx buy - Bitget
Lilly moves beyond blockbuster obesity drugs with $1.2 billion Ventyx buy By Reuters - Investing.com
Ventyx Biosciences Signs Multiple Material Agreements - TradingView — Track All Markets
Eli Lilly stock jumps after $1.2B Ventyx buy as obesity-pill bets come into focus - TechStock²
Eli Lilly (LLY) Set to Acquire Ventyx Biosciences in Cash Deal - GuruFocus
Eli Lilly, IBD Stock Of The Day, Offers Two Entries On Rumored Buyout Rally - Investor's Business Daily
Lilly confirms $1.2B takeover of Ventyx Biosciences - breakingthenews.net
Eli Lilly and Co will acquire all outstanding shares of Ventyx Biosciences in an all-cash transaction at a price of $14.00 per common share. - 富途牛牛
Eli Lilly to acquire Ventyx Biosciences in $1.2B deal - Axios
Eli Lilly to acquire Ventyx Biosciences for $14.00 per share in cash - TipRanks
Lilly to pay $1.2B for Ventyx and its NLRP3 drugs - Endpoints News
Eli Lilly to buy Ventyx Biosciences in $1.2 billion deal - Yahoo! Finance Canada
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases - PR Newswire
Ventyx Stocks Soar Amid Acquisition Talks - StocksToTrade
Eli Lilly To Acquire Ventyx Biosciences In $1.2 Billion Deal - Stocktwits
Eli Lilly Shares Surge On Report Of Potential Ventyx Acquisition - Benzinga
Lilly in talks to buy Ventyx Biosciences for more than $1B, WSJ reports - Indianapolis Business Journal
Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more - CNBC
Eli Lilly stock climbs on Ventyx buyout talk as dealmaking takes center stage - TechStock²
Eli Lilly (LLY) Nears $1 Billion Acquisition of Ventyx Biosciences (VTYX) - GuruFocus
BRIEF—Ventyx rockets on reports of Lilly buyout - The Pharma Letter
Eli Lilly nears deal for Ventyx Biosciences at $14/shareWSJ - MSN
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday - Benzinga
Companies are discussing a deal in which Eli Lilly would pay $14 a share in cash for Ventyx- WSJ - MarketScreener
Ventyx Biosciences stock skyrockets nearly 70% after Eli Lilly offer - medwatch.com
Exclusive | Eli Lilly Nears Deal for Biotech Ventyx - The Wall Street Journal
Stock Movers: Ventyx, Mobileye, Strategy - Bloomberg.com
Ventyx Takeover Talks Boost Stock - timothysykes.com
Stock Market Today: Dow Futures Up, S&P 500 And Nasdaq Slip As ADP Jobs Data Signals Modest Rebound— Mobileye, Penguin Solutions In Focus (UPDATED) - Benzinga
Ventyx Biosciences (VTYX) Stock: Eli Lilly in Advanced Acquisition Talks Worth Over $1 Billion - Blockonomi
Strategy, Sandisk, Warner Bros., Mobileye, First Solar, Ventyx, and More Market Movers - Barron's
Ventyx Biosciences said to be in takeover talks with Eli Lilly, shares surge - Sharecast.com
Is Lilly negotiating to buy Ventyx Bio? - pharmaphorum
Morning Market Movers: VTYX, CDIO, GLUE, EMAT See Big Swings - RTTNews
Ventyx Biosciences Surges On Eli Lilly Buyout Speculation - Nasdaq
Eli Lilly Nears Deal to Buy Ventyx Biosciences for Over $1 Billi - GuruFocus
Biggest stock movers Wednesday: VTYX, MBLY, and more (NASDAQ:MBLY) - Seeking Alpha
Eli Lilly Nears Deal to Buy Ventyx Biosciences for Over $1 Billion - Yahoo Finance
These stocks are moving the most today: Strategy, SanDisk, Ventyx Biosciences, Mobileye, and more - MSN
Strategy, Sandisk, Ventyx Biosciences, Mobileye, Cal-Maine Foods, and More Movers - Barron's
Eli Lilly Is Closing In on Deal With Biotech Ventyx, WSJ Says - Bloomberg.com
Trending tickers: Micron, Sandisk Corporation, Ventyx Biosciences, BP and Reckitt - Yahoo Finance UK
These Stocks Are Moving the Most Today: Strategy, Sandisk, Ventyx Biosciences, Mobileye, and More -- Barrons.com - 富途牛牛
Ventyx Biosciences (VTYX) Stock: Eli Lilly Acquisition Talks Send Shares Soaring 62% - CoinCentral
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus Deal - Medical Dialogues
Biggest stock movers Wednesday: VTYX, MBLY, and more - MSN
Ventyx Biosciences stock jumps premarket as Eli Lilly buyout talks fuel takeover buzz - TechStock²
大文字化:
|
ボリューム (24 時間):